Surgical approaches for lumbar interbody fusion have grown progressively less invasive over the last twenty years. Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) currently stands as the standard, successfully preserving paraspinal musculature while satisfying the structural requirements of a traditional fusion. Recently, uniportal and biportal endoscopic techniques have sparked a practical debate: does this further reduction in access truly translate into better outcomes? The accompanying article, “Endoscopic Lumbar Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Structured Debate and International Practice Patterns,” evaluates this by combining a literature review with a survey of 106 surgeons from 35 countries [1]. The authors successfully distinguish the immediate postoperative benefits of ultra-minimally invasive access from the long-term biological requirements of a solid fusion.
Endoscopic fusion has moved past its initial growing pains to become a legitimate tool for specific degenerative conditions. Uniportal endoscopic transforaminal lumbar interbody fusion (UE-TLIF) and biportal endoscopic transforaminal lumbar interbody fusion (BE-TLIF) systems now enable effective neural decompression, endplate preparation, and cage placement through exceptionally narrow corridors. Compared with MIS-TLIF, these techniques reliably reduce blood loss, early postoperative back pain, and hospital length of stay, though midterm functional outcomes remain comparable [2,3]. These are tangible benefits, yet we have to keep them in perspective. Because MIS-TLIF is inherently muscle-sparing, the transition from tubular retractors to an endoscope offers a much smaller leap in tissue preservation than the original shift from open surgery to MIS-TLIF.
Achieving arthrodesis requires more than a minimal incision. Surgeons still have to execute thorough disc clearance, protect the endplates, insert an appropriately sized cage, and correct segmental alignment. While endoscopic optics deliver unmatched magnification of the working zone, the restricted corridor inherently limits instrument maneuverability during critical reconstructive phases like endplate decortication. This mechanical constraint is especially apparent when dealing with severe disc collapse, advanced arthropathy, or poor bone quality. Just because a segment can be fused endoscopically does not mean it always should be. For complex anatomical challenges, the broader working channel of MIS-TLIF maintains distinct advantages.
The current literature also warrants careful scrutiny. While many comparative trials show similar fusion rates and functional outcomes at midterm follow-up, long-term durability is still largely unproven. Much of the available data are retrospective, relying on small cohorts with limited observation periods [2,3]. The absence of a statistically significant difference at 12 months tells us very little about late-stage failures like pseudarthrosis or delayed cage subsidence. Furthermore, some studies highlight a higher incidence of early neurological symptoms and index-level reoperations following endoscopic procedures [4,5]. We do not yet know whether these issues stem from the physical limits of the technique, suboptimal patient selection, or the steep learning curve.
The international survey offers a revealing look at how practicing spine surgeons navigate these trade-offs. Respondents strongly favored endoscopy for approach-related benefits, with 89.6% prioritizing it for soft-tissue preservation, 81.1% for visualization, and 74.5% for recovery time [1]. However, consensus disappeared when respondents were asked about core reconstructive endpoints. The panel found no clear advantage for endoscopy regarding fusion stability, midterm clinical outcomes, complication profiles, or revision rates. This division is highly informative: surgeons clearly trust the perioperative benefits of endoscopy but remain skeptical that it produces a mechanically superior fusion. Procedural preference also shifted based on the pathology, with endoscopy favored for straightforward single-level disease and MIS-TLIF remaining the preferred option for 2-level cases.
Patient safety ultimately comes down to surgical experience. Endoscopic fusion requires a completely different skill set from standard endoscopic decompression, demanding meticulous disc preparation, safe cage insertion past the nerve root, and effective hemostasis under continuous fluid irrigation. The learning curve is steep, and while proficiency scales with case volume, estimates for the required number of procedures remain highly variable [6]. MIS-TLIF also has a learning curve, but its long history ensures that training pathways, complication-management protocols, and faculty support are already deeply entrenched. Surgeons looking to adopt endoscopic fusion need structured proctorships; mastering an endoscopic discectomy does not automatically guarantee competence in endoscopic interbody reconstruction.
The economic reality of these procedures is also unsettled. While faster recovery and shorter hospital stays imply cost savings, these financial gains are often offset by capital investments in endoscopic towers, disposable instruments, and longer operative times during the initial learning phase [7,8]. Published economic analyses present conflicting data, largely because healthcare costs vary drastically across different regions and systems. Demonstrating true economic superiority will require robust trials that calculate total treatment costs, quality-adjusted life years, and long-term revision burdens rather than simply measuring the initial hospital bill.
Looking ahead, the focus of our research needs to shift. We know endoscopic fusion is technically feasible; we now need to determine exactly which clinical scenarios make it a better choice than MIS-TLIF. Future prospective randomized trials should evaluate UE-TLIF and BE-TLIF independently, using standardized criteria for fusion success, cage subsidence, and sagittal alignment. Study designs must directly account for surgeon experience, patient bone density, and anatomical complexity. Most importantly, follow-up needs to extend past 5 years to ensure that short-term perioperative gains do not compromise the long-term durability of the reconstruction.
Ultimately, this debate positions endoscopic fusion exactly where it belongs: as a highly effective option for carefully selected patients with single-level lumbar degenerative disease [1]. We have clearly documented its perioperative advantages, but its long-term reconstructive superiority remains unproven. MIS-TLIF remains the reliable workhorse: a familiar, versatile procedure that comfortably handles broader surgical access and complex pathology. The decision between them should not hinge on the size of the incision but on which technique provides the safest decompression, the most robust reconstruction, and the most durable long-term fusion for the specific patient on the table.
Footnotes
Conflict of Interest
The author has nothing to disclose.
REFERENCES
- 1.Boonsirikamchai W, Jitpakdee K, Park D, et al. Endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion: a structured debate and international practice patterns. Neurospine. 2026;23:832–52. doi: 10.14245/ns.26521616.0808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kang MS, You KH, Choi JY, et al. Minimally invasive transforaminal lumbar interbody fusion using the biportal endoscopic techniques versus microscopic tubular technique. Spine J. 2021;21:2066–77. doi: 10.1016/j.spinee.2021.06.013. [DOI] [PubMed] [Google Scholar]
- 3.Chen X, Xie J, Zhang Z, et al. Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study. PLoS One. 2025;20:e0333165. doi: 10.1371/journal.pone.0333165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gerling M, Baker M, Stanton E, et al. Closing the gap: the incidence of complications in minimally invasive tubular, endoscopic, and robotic-assisted transforaminal lumbar interbody fusion procedures. World Neurosurg. 2024;189:e492–7. doi: 10.1016/j.wneu.2024.06.101. [DOI] [PubMed] [Google Scholar]
- 5.Youn MS, Cho YJ, Goh TS, et al. Comparison of index-level reoperation-free survival and complication rates between endoscopic and conventional transforaminal lumbar interbody fusion: a retrospective comparative study in Korea. Asian Spine J. doi: 10.31616/asj.2025.0590. 2026 Jul 8. doi: 10.31616/asj.2025.0590. [Epub] [DOI] [PubMed] [Google Scholar]
- 6.Guo W, Ye J, Li T, et al. Evaluation of the learning curve and complications in unilateral biportal endoscopic transforaminal lumbar interbody fusion: cumulative sum analysis and risk-adjusted cumulative sum analysis. J Orthop Surg Res. 2024;19:194. doi: 10.1186/s13018-024-04674-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Xu H, Yu L, Xiao B, et al. Comparison of outcomes between endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion in patients with single-level lumbar degenerative disease: a retrospective study. World Neurosurg. 2024;183:e98–108. doi: 10.1016/j.wneu.2023.11.092. [DOI] [PubMed] [Google Scholar]
- 8.He Y, Liu JW, Fang M, et al. Comparison of short-term effectiveness between unilateral biportal endoscopic and MEDassisted transforaminal lumbar interbody fusion for mild single-segment lumbar spondylolisthesis. BMC Musculoskelet Disord. 2025;26:631. doi: 10.1186/s12891-025-08892-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
